Valtronic can now offer Glass Encapsulation to medical device companies who produce active implants. Our first customer application for this product is for an ingestible pill.
Valtronic can now offer Glass Encapsulation to medical device companies who produce active implants. Our first customer application for this product is for an ingestible pill.
The JewelPumpTM represents the most advanced use of microfluidic MEMS (Micro-Electro-Mechanical Systems) technology in diabetes treatment and will be manufactured in multiple Valtronic facilities.
Valtronic Group appoints Dr. Martin Zimmermann as CEO of the Group and President of Valtronic Technologies (Suisse).